Price controls on pharmaceuticals may sound compassionate, but they function as government-mandated discounts. That means fewer lifesaving drugs reaching patients. @SenRickScott@RepGusBilirakis#BadMedicineFL
https://t.co/z3n3xUBGUX
Patients deserve confidence in the medications they take. The rapid growth of counterfeit weight-loss products highlights the urgent need for stronger oversight and enforcement against pharmaceutical fraud. @scottforflorida@DrNealDunnFL2#BadMedicineFL
https://t.co/yBuwKxFesG
Most Favored Nation drug pricing imports European-style price fixing into the U.S. Price controls reduce competition, distort markets, and slow medical innovation. @SenRickScott@RepKatCammack#BadMedicineFL
https://t.co/x0UTkC4rFb
When compounded GLP-1 drugs are sold with unclear sourcing, inconsistent standards, or vague labeling, consumers are left navigating in the dark. @scottforflorida@DrNealDunnFL2#badmedsFL
https://t.co/iDI2EpjVul
Health insurance CEOs told Congress they don’t control costs — yet heavy consolidation, opaque pricing, and administrative barriers leave patients stuck with fewer options and higher bills. @scottforflorida@repgusbilirakis#NoGPO
https://t.co/RCxA2ztHcv
Strong litigation finance rules can preserve ethical legal practice and keep attorneys focused on justice, not funder incentives. @Clay_Yarborough@Jaytrumbull@TomFLCALA
https://t.co/y9eoVlCWgF
When profits depend on diagnosis codes, not outcomes, you get upcoding — not innovation. Medicare Advantage needs transparency, competition, and patient choice. @scottforflorida@repgusbilirakis#NoGPO
https://t.co/R6FIMobaCL
Medicare Advantage has become a profit center for connected organizations, not a value engine for seniors. Distorted incentives always inflate costs. @senAshleyMoody@repcarlos#NoGPO
https://t.co/4DFsHSpg3O
When patients seek GLP-1 medications through trusted physicians, dosing and safety are monitored. But buying from social media “pharmacies” can be deadly. @repgusbilirakis@senrickscott#badmedicineFL
https://t.co/Fy8Bow78QK
Other countries extort our pharmaceutical makers to shift costs onto the American consumer.” Time to stop letting foreign freeloaders off the hook. @scottforflorida@vernbuchanan#betterwaysFL
https://t.co/KWieqTZQCl
Patients desperate for weight-loss meds are being preyed on by illegal sellers. Education, enforcement, and transparency are essential to protect public health. @senrickscott@repgusbilirakis#badmedicineFL
https://t.co/b814hTwiuI
When scammers repackage insulin and sell it as Ozempic, that’s not gray-market activity — that’s criminal fraud putting lives at risk. @gregsteube@byrondonalds@rondesantis#safemedsfl
https://t.co/ICm31ncjKX
Rogue suppliers overseas are dumping unsafe compounds into U.S. markets, and slick telehealth ads are preying on seniors. @SenRickScott & @JimJustice_WV are right to investigate. #badmedicineFL
https://t.co/o8j61Nrcor
Parents know shortcuts often cost more in the long run. Fake GLP-1 drugs skip safety trials and can cause overdoses, dehydration, and even hospitalizations. Don’t gamble with your health. @repgusbilirakis@gregsteube#SafeMedsFL
https://t.co/Zz7b7EBvPZ
Our families deserve medicine we can trust. Every unsafe pill that slips through weak enforcement puts Americans at risk. @repgusbilirakis@gregsteube@repcarlos#safemedsfl
https://t.co/emGuFXZUlj
Medicare Advantage keeps seniors healthier: fewer hospitalizations and more preventive care. The No Upcode Act puts those gains at risk. @Senrickscott@scottforflorida#MAWorksFL
https://t.co/cbJhL0LvoE
The coalition calls for reforms that unleash private sector innovation while protecting patient access and choice. Price controls will restrict innovation. @vernbuchanan@repaaronbean@scottforflorida#betterwaysFL
https://t.co/WLGfP6sLkP
Europe’s price caps mean patients wait years for new medicines—and often never get them at all. America leads in cures because we reject socialist-style controls. @repaaronbean@scottforflorida#betterwaysFL
https://t.co/nDUn3odR8a
Black-market “weight-loss meds” seized in Ohio were unapproved & dangerous. Florida leaders need to step up. FDA & Florida’s Board of Pharmacy must do their jobs to protect our citizens. @DrNealDunnFL2@RepGusBilirakis#safemedsFL
https://t.co/lIczLKhQzn